Internal Medicine, Endocrinology, Diabetes, & Metabolism · Asheville, NC
NPI
1841400702
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
750 Alliance Ct
Asheville, NC, 28806
Phone (828) 670-6812
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
6,577 services
Medicare patients, 2024
630
Average age 72
Drug cost, 2024
$5.2M
8,412 prescriptions
Company payments, 2025
$43K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor R Marlar was code J0897 (injection, denosumab, 1 mg), 2,400 times for 22 patients. In total Victor R Marlar billed 6,577 services in 57 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,400 | 22 | $20.26 | $49K |
| 99214 Office E&M - Established | Office | 623 | 486 | $83.64 | $52K |
| 83036 Blood Count | Office | 502 | 363 | $9.33 | $4,685 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 483 | 396 | $12.52 | $6,049 |
| 36415 Venipuncture Blood Collection | Office | 306 | 249 | $8.65 | $2,647 |
| 84443 Clinical Chemistry | Office | 259 | 215 | $16.33 | $4,230 |
| 84439 Clinical Chemistry | Office | 233 | 190 | $8.80 | $2,051 |
| 95251 Test - Miscellaneous | Office | 209 | 148 | $25.28 | $5,283 |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 145 | 48 | $64.54 | $9,358 |
| 99425 Chronic, Principal, and Transitional Care Management | Office | 130 | 46 | $46.80 | $6,085 |
| 99215 Office E&M - Established | Office | 106 | 93 | $126.59 | $13K |
| 80048 Clinical Chemistry | Office | 78 | 75 | $8.29 | $647 |
| 80053 Clinical Chemistry | Office | 78 | 76 | $10.22 | $797 |
| 82306 Clinical Chemistry | Office | 76 | 70 | $29.01 | $2,205 |
| 84481 Clinical Chemistry | Office | 75 | 60 | $16.38 | $1,228 |
By year: 2022 $176K for 6,501 services; 2023 $263K for 11,292 services; 2024 $191K for 6,577 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 502 | 363 | $9.33 | $4,685 |
| 36415 Venipuncture Blood Collection | 306 | 249 | $8.65 | $2,647 |
| 84443 Clinical Chemistry | 259 | 215 | $16.33 | $4,230 |
| 84439 Clinical Chemistry | 233 | 190 | $8.80 | $2,051 |
| 80048 Clinical Chemistry | 78 | 75 | $8.29 | $647 |
| 80053 Clinical Chemistry | 78 | 76 | $10.22 | $797 |
| 82306 Clinical Chemistry | 76 | 70 | $29.01 | $2,205 |
| 84481 Clinical Chemistry | 75 | 60 | $16.38 | $1,228 |
| 85025 Blood Count | 61 | 60 | $7.61 | $464 |
| 80061 Clinical Chemistry | 60 | 59 | $12.25 | $735 |
Medicare prescription drug claims, 2024
In 2024, the drug Victor R Marlar prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,069 prescriptions and refills. In total Victor R Marlar wrote 8,412 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,069 | 1,712 | 234 | $1.6M |
| Levothyroxine Sodium Generic | 670 | 1,795 | 181 | $6,219 |
| Metformin Hcl Er Metformin Hcl | 403 | 1,069 | 116 | $4,549 |
| Tresiba Flextouch U-200 Insulin Degludec | 368 | 633 | 94 | $428K |
| Synthroid Levothyroxine Sodium | 353 | 789 | 80 | $34K |
| Mounjaro Tirzepatide | 304 | 390 | 65 | $409K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 217 | 313 | 49 | $364K |
| Jardiance Empagliflozin | 213 | 396 | 62 | $227K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 213 | 388 | 53 | $227K |
| Metformin Hcl Generic | 192 | 509 | 56 | $1,523 |
| Methimazole Generic | 190 | 438 | 54 | $1,980 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 160 | 292 | 32 | $181K |
| Novolog Flexpen Insulin Aspart | 158 | 314 | 59 | $73K |
| Pioglitazone Hcl Generic | 146 | 371 | 43 | $1,505 |
| Rosuvastatin Calcium Generic | 146 | 377 | 42 | $1,566 |
Brand drugs: 4,920 claims; generic drugs: 2,968 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor R Marlar $43K ($43K in general payments such as food, travel and fees) from 18 companies. The largest payer was Novo Nordisk Inc with $34K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 38 | $34K |
| Neurocrine BioSciences, Inc. NBIX | 13 | $5,186 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $3,769 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $85.71 |
| Amgen Inc. AMGN | 5 | $84.34 |
| Corcept Therapeutics CORT | 4 | $65.73 |
| Insulet Corporation PODD | 3 | $59.95 |
| Lilly USA, LLC LLY | 3 | $55.44 |
| Beta Bionics, Inc. BBNX | 2 | $44.92 |
| Recordati_rare_diseases_inc. | 2 | $37.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.